Akten
Product Images NDC 17478-792

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Akten (NDC 17478-792). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Akorn, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Akt00 0013 01

Chemical structure diagram depicting the molecular structure of the active ingredient in Akten. The diagram shows several connected atoms including carbon, nitrogen, oxygen, and hydrogen, illustrating the chemical composition of the compound.*

FDA Label Image

Akt00 0013 02

Label for Akten 3.5% lidocaine HCl ophthalmic gel, 1 mL, preservative free, sterile, Rx only. Manufactured by Akorn, Inc., Lake Forest, IL. The label specifies use for topical ophthalmic application only and single-patient use, with instructions to discard unused portion.*

FDA Label Image

Akt00 0013 03

The packaging label for Akten (lidocaine hydrochloride ophthalmic gel) 3.5% by Akorn displays key details including that it is for topical ophthalmic use only, preservative free, sterile, and supplied in a 1 mL size. It features warnings about keeping out of reach of children, storage instructions, inactive ingredients, and a note to discard unused portions. The label also states it is manufactured by Akorn, Inc. in Lake Forest, IL, and made in Switzerland.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.